The cytokine erythropoietin (EPO) is the master regulator of erythropoiesis. Intriguingly, many studies have shown that the cognitive performance of patients receiving EPO for its hematopoietic effects is enhanced, which prompted the growing interest in the use of EPO-based strategies to treat neuropsychiatric disorders. EPO plays key roles in brain development and maturation, but also modulates synaptic transmission. However, the mechanisms underlying the latter have remained elusive. Here, we show that acute (40-60 min) exposure to EPO presynaptically downregulates spontaneous and afferentevoked excitatory transmission, without affecting basal firing of action potentials. Conversely, prolonged (3 h) exposure to EPO, if followed by a recovery period (1 h), is able to elicit a homeostatic increase in excitatory spontaneous, but not in evoked, synaptic transmission. These data lend support to the emerging view that segregated pathways underlie spontaneous and evoked neurotransmitter release. Furthermore, we show that prolonged exposure to EPO facilitates a form of hippocampal long-term potentiation that requires noncanonical recruitment of calcium-permeable AMPA receptors for its maintenance. These findings provide important new insight into the mechanisms by which EPO enhances neuronal function, learning, and memory.
Introduction
Erythropoietin (EPO) is a pleiotropic hormone from the type I cytokine super-family best known as a crucial regulator of erythropoiesis and tissue oxygenation homeostasis. In addition, EPO signaling has been shown to play key roles in the central nervous system (CNS), where neurons and astrocytes express a specific nonhematopoietic EPO receptor (Fond et al. 2012) . EPO is an important regulator of neuronal proliferation and migration during CNS development and also following injury to the mature brain, such as during poststroke recovery (Tsai et al. 2006) . Intriguingly, in addition to its role in neurogenesis, early studies reported positive cognitive effects in patients regularly receiving EPO for chronic kidney disease (Kambova 1998; Pickett et al. 1999) . Similar procognitive effects have since been reported in patients with schizophrenia (Ehrenreich et al. 2007 ), bipolar disorder (Miskowiak et al. 2014 ) and type one diabetes (Kristensen et al. 2013 ).
These cognitive-enhancing effects might be partially explained by the fact that EPO raises hemoglobin levels and improves brain oxygenation or could reflect the antiapoptotic, antioxidative, and anti-inflammatory properties of this cytokine (Brines and Cerami 2005; Sirén et al. 2009; Fond et al. 2012) . However, treatment with EPO has been shown to amplify the expression of proplasticity genes in an experimental stroke model at early time points, even before EPO would be expected to reduce inflammation or neuronal apoptosis (Mengozzi et al. 2012) .
In keeping with these data, recent evidence indicates that EPO directly modulates neuronal activity and plasticity (Adamcio et al. 2008; Kamal et al. 2011; Sargin et al. 2011 ). However, differences in the experimental models used to investigate EPO signaling have yielded some inconsistencies in results (Supplementary Table 1) . We propose that, at least partially, this is due to the fact that differences in effect between acute neuronal tuning versus network effects of prolonged exposure have not been accounted for.
Here, we directly compared the effects of acute EPO application (aEPO) with those of a more prolonged exposure (pEPO) using ex vivo and in vitro experimental models that isolate the actions of EPO to the neuronal/astrocytic compartment. Our results demonstrate that acute EPO acts as an inhibitor of synaptic transmission, downregulating excitatory and upregulating inhibitory spontaneous activity. In contrast, more prolonged exposure (3 h) to EPO, followed by a recovery period (1 h), resulted in opposite, homeostatic changes in spontaneous synaptic transmission. These results resemble those observed following exposure to an activity deprivation (AD) paradigm with tetrodotoxin (TTX, 1 μM), a sodium channel blocker, and APV (50 μM), a N-methyl-D-aspartate receptor (NMDAR) antagonist (Sutton et al. 2006; Félix-Oliveira et al. 2014) . Therefore, in order to better understand the consequences of EPO's homeostatic actions, we directly compared the effects of prolonged EPO against those of the AD protocol on network excitability and hebbian synaptic potentiation.
Materials and Methods

Animals
All experiments were conducted using Wistar or Sprague-Dawley rats, as indicated. Animals were kept under standardized temperature, humidity and lighting conditions, with access to water and food ad libitum. All animal procedures were carried out according to the Portuguese law and the European Community Guidelines for Animal Care (European Union Council Directive-2010/63/EU). Throughout the underlying experimental work, care was taken to minimize the number of animals sacrificed.
Primary Hippocampal Cultures
Pregnant Sprague-Dawley rats were obtained from Harlan Interfauna Iberia (Barcelona, Spain). Animals were deeply anesthetized with halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) in an anesthesia chamber before being sacrificed by decapitation. Briefly, embryos (E17-E18) were rapidly removed from the uterus, their brains removed and placed in cold Ca 2+ -and Mg
2+
-free Hank's balanced salt solution supplemented with 0.37% glucose (HBSS-glucose). After brain isolation, meninges were gently removed from the hemispheres. All hippocampi were collected in fresh HBSS-glucose and trypsinization was carried out (0,350 mL of 2,5% trypsin) at 37°C for 15 min in a water bath. Afterwards, trypsin solution was gently removed and 30% fetal bovine serum (FBS) in HBSS-glucose was added and let stand for 5 min at room temperature (RT, (22) (23) (24) to quench trypsin activity. The pellet was resuspended in Neurobasal medium (Neurobasal-B27: Neurobasal supplemented with 0.5 mM glutamine, 2% B27, 25 U/mL penicillin/streptomycin) and 25 mM glutamic acid. Cell suspension was filtered using a nylon filter (Cell Strainer 70 μM, BD Falcon) and cell density was determined by counting cells in a 0.4% trypan blue solution using a hemacytometer. Cells were plated at 4 × 10 4 cells/cm 2 in 24-well plates with glass coverslips (Marienfeld, Germany) coated with poly-D-lysine (PDL, 50 μg/mL). The cultures were maintained for a maximum of 21 days, in an incubator with a humidified 37°C and 5% CO 2 atmosphere with no media exchange.
Acute Slice Preparation and Incubation
Young Wistar rats (3-5 weeks old) were killed by decapitation under deep isoflurane anesthesia. The brain was quickly removed, hemisected, and both hippocampi were dissected free within ice-cold dissecting solution containing (in mM): 110 sucrose, 2.5 KCl, 0.5 CaCl 2 , 7 MgCl 2 , 25 NaHCO 3 , 1.25 NaH 2 PO 4 , and 7 glucose; previously gassed with 95% O 2 and 5% CO 2 , pH 7.4. For extracellular recordings, slices (350 μm-thick) were cut perpendicularly to the long axis of the hippocampus with a McIlwain tissue chopper (unless stated otherwise) and allowed to recover functionally and energetically for at least 60 min at RT, in a resting chamber filled with artificial cerebrospinal fluid (aCSF) (containing, in mM: 124 NaCl, 3 KCl, 1.25 NaH 2 PO 4 , 26 NaHCO 3 , 1 MgSO 4 , 2 CaCl 2 , and 10 glucose), previously gassed with 95% O 2 and 5% CO 2 , pH 7.4.
For patch-clamp recordings, acute hippocampal (300 μm-thick) slices were cut using a vibratome (VT1000 S; Leica, Nussloch, Germany) in the aforementioned ice-cold dissecting solution. Slices were first incubated for 30 min at 35°C in gassed aCSF followed by at least 60 min of recovery at RT.
Hippocampal slices were incubated with vehicle, with EPO (2.4 IU/mL) alone, with both TTX (1 μM) and AP-V (50 μM) or with these 3 drugs simultaneously, for 3 h, at RT, in gassed aCSF. For some experimental designs, this was followed by a washout/recovery period of 1 h in gassed aCSF at RT, as indicated. EPO concentration (2.4 IU/mL) corresponds to a concentration 8 times (2 3 ) higher than that used by others in cultured cells (Adamcio et al. 2008) . This was done since it is more difficult for EPO to permeate hippocampal slices (300-350 μm-thick), than cultured cells (in monolayer).
Electrophysiology
Extracellular Ex Vivo Recordings
Slices were transferred to a submerging chamber (1 mL) and continuously superfused at a 3 mL/min rate with gassed aCSF at 32°C. Evoked orthodromic field excitatory postsynaptic potentials (fEPSP) were recorded extracellularly through a microelectrode filled with 4 M NaCl (2-8 MΩ resistance) placed in the stratum radiatum of the CA1 area, as previously described (Rodrigues et al. 2014) . (Anderson and Collingridge 2001) . All the protocols detailed below were started only after a stable baseline of at least 20 min. In the tracings shown, the stimulus artifact was truncated for clarity.
Basal Synaptic Transmission. Alterations in synaptic transmission induced by EPO (2.4 IU/mL) were evaluated as % change in the average slope of the fEPSP 50-60 min after EPO application, relatively to the average slope of the fEPSP measured during the 10 min that preceded addition of EPO to the superfusing solution.
PPF Recordings. PPF was quantified as the percentage of slope facilitation between 2 consecutive fEPSPs (fEPSP2/fEPSP1) elicited with a 50-ms interstimulus interval. PPFs were continuously elicited for 60 min; EPO was added to the superfusing solution 20 min after having started the PPF protocol. Alterations in PPF efficiency induced by EPO (2.4 IU/mL) were evaluated as % change in the average PPF ratio 30-40 min after EPO application, relatively to the average PPF ratio measured during the 10 min that preceded the addition of EPO to the superfusing solution. As a control, in different slices, PPFs were continuously elicited for 60 min, adding only vehicle to the superfusing solution, to test whether continuously eliciting PPFs for that time period would per se change PPF efficiency.
Input/Output Curves. The stimulus delivered to the slice was decreased until no fEPSP was evoked and subsequently increased in 20 μA steps. Data from 3 consecutive averages of 8 fEPSPs were collected for each stimulation intensity. Inputs delivered to slices typically ranged from 80 μA to a supramaximal stimulation of 320 μA. fEPSP slope was plotted as a function of stimulus intensity. The maximum slope values were obtained by extrapolation upon nonlinear fitting of the I/O curve and an F test was used to determine differences between the parameters. Whenever the stimulus was intense enough to elicit a population spike (depolarization that follows the fEPSP), its amplitude was measured. Each popspike amplitude replicate was plotted as a function of the slope of the associated fEPSP and the popspike/fEPSP ratio calculated as the quotient between these values.
LTP Induction. A weak LTP-inducing θ-burst protocol consisting of 4 trains of 100 Hz, 4 stimuli, separated by 200 ms was used (1 × 4 × 4). The intensity of the stimulus was never changed throughout the experiment. LTP magnitude was quantified as the % change in the average of the fEPSP taken from 50 to 60 min after LTP induction relative to the average slope of the fEPSP measured during the 10 min that preceded induction of LTP. Post-tetanic potentiation (PTP) was assessed as the average fEPSP slope obtained in the first 8 min after LTP induction (Habets and Borst 2007) .
For the experiments in Figure 7 , stimulation was delivered, every 10 s, alternatively to 2 independent pathways of the Schaffer collateral/commissural fibers. In each individual experiment, the LTP-inducing paradigm was delivered to one of the pathways and, 1 h thereafter, to the other pathway; each pathway was used as control or test in alternate days. NASPM (20 μM) was added to the superfusing solution 20 min after the induction of the second LTP. This protocol allowed to test the effect of NASPM on LTP maintenance, with the first LTP serving as an internal control. The LTP-inducing protocol used was the same and LTP magnitude was quantified as explained above.
Antidromic Population Spike (Popspike) Recordings. Hippocampal slices used were prepared as described above for patch-clamp recordings. Evoked antidromic popspikes were recorded extracellularly through a microelectrode filled with 4 M NaCl (2-8 MΩ resistance) placed in CA1 pyramidal cell layer. Antidromic responses were evoked by stimulation in the alveus, every 15 s, by a bipolar concentric wire electrode (Kabakov et al. 2012) . The initial intensity of the stimulus was adjusted to obtain a submaximal popspike amplitude with minimal contamination. Averages of 8 responses were obtained and the popspike amplitude was calculated as the amplitude from the popspike peak to the intersection with an interpolated tangent line drawn between the prepopspike peak and the post-popspike peak (Fig. S1A ). Recordings were obtained with an Axoclamp 2B amplifier (Axon Instruments, Foster City, CA), digitized and continuously stored on a personal computer with the LTP program (Anderson and Collingridge 2001) . In order to demonstrate that nonsynaptic excitatory transmission underlies the popspikes we recorded, control experiments were performed (for a representative experiment, see Fig. S1B ). Alterations in popspike amplitude induced by EPO (2.4 IU/mL) were evaluated as % change in the average amplitude of the popspike 50-60 min after EPO application, relatively to the average amplitude of the popspike measured during the 10 min that preceded addition of EPO to the superfusing solution.
Patch-Clamp Recordings
Whole cell patch-clamp recordings were obtained either from hippocampal CA1 pyramidal cells or from hippocampal cultured neurons, as indicated. These were visualized with an upright microscope (Zeiss Axioskop 2FS) equipped with infrared video microscopy and differential interference contrast optics. Recordings were performed at RT in current-clamp or voltageclamp mode with an Axopatch 200B (Axon Instruments) amplifier. For current-clamp recordings and for miniature or spontaneous excitatory postsynaptic current (mEPSC or sEPSC, respectively) recordings, patch pipettes (4-to 7-MΩ resistance) were filled with an internal solution containing (in mM): 125K-gluconate, 11 KCl, 0.1 CaCl 2 , 2 MgCl 2 , 1 EGTA, 10 HEPES, 2 MgATP, 0.3 NaGTP, and 10 phosphocreatine, pH 7.3, adjusted with 1 M KOH, 280-290 mOsm. For miniature inhibitory postsynaptic current (mIPSC) recordings and AMPA-and NMDA-mediated responses, the internal solution contained (in mM): 125 CsCl, 8 NaCl, 1 CaCl 2 , 10 EGTA, 10 HEPES, 10 glucose, 5 MgATP, and 0.4 NaGTP, pH 7.2, adjusted with CsOH (50 wt% in H 2 O), 280-290 mOsm. Acquired signals were filtered using an in-built, 2-kHz, 3-pole Bessel filter, and data were digitized at 5 or 10 kHz under control of the pCLAMP 10 (Molecular Devices) software program. The junction potential was not compensated for, and offset potentials were nulled before giga-seal formation. Small voltage steps (−5 mV, 50 ms) were used to monitor the access resistance throughout experiments. The holding current was also constantly monitored and experiments in which any of these parameters varied by more than 20% were discarded.
Current-Clamp Recordings. The resting membrane potential (RMP) was measured immediately upon establishing whole cell configuration. Changes in membrane potential and action potentials were evoked under current-clamp mode by injection of 500 ms current pulses (25-275 pA in 25 pA increments) from an initial holding potential (V h ) of −70 mV. The threshold for action potential (AP) generation was determined as the difference between the RMP (V m ) and the membrane potential at which phase plot slope reached 10 mV/ms (V t ) (Naundorf et al. 2005) . When studying the effect of acute EPO/vehicle superfusion upon spiking frequency, neurons were initially currentclamped to −60 mV (the closest to our sample average RMP) and this holding current was kept constant throughout the experiment. After 10 min of baseline recording, EPO (2.4 IU/mL) or vehicle were added to the superfusion solution and membrane potential variations were recorded for at least 40 min. The average spiking frequency was calculated as the frequency of APs within the entire period of superfusion with EPO/vehicle. Spontaneous Activity. Spontaneous mEPSCs were recorded in aCSF supplemented with TTX (500 nM) and gabazine (2 μM). Spontaneous mIPSCs were recorded in aCSF supplemented with TTX (500 nM) and kynurenic acid (1 mM). For sEPSC recordings only gabazine (2 μM) was added to perfusion. Analysis of spontaneous events was performed using the Synaptosoft Mini Analysis Program software with the amplitude threshold for event detection set at 3x the average root-mean-square noise.
Synaptic Failure Rate. These experiments were performed using minimum stimulation. Recordings were performed in the continuous presence of picrotoxin (100 μM). Synaptic responses were obtained with a bipolar electrode placed over Schaffer collateral fibers and stimuli (100 μs) were delivered every 5 s. AMPAmediated responses were measured as the peak amplitude value of the EPSC at −60 mV and NMDA-mediated responses as the peak amplitude value of the EPSC at +40 mV, at a latency where AMPA responses had fully decayed (30-60 ms) (Arendt et al. 2013) . The criterion used for defining success of synaptic transmission was peak amplitude values greater than 20 pA for AMPA-mediated responses and 10 pA for NMDA-mediated responses. Failure rate was calculated as a percentage of failed evoked responses over 50 sweeps. In the amplitude scatter plots, for ease of visualization, the amplitudes of failure trials were plotted as zero. To facilitate the interpretation of the tracings shown, the stimulus artifact was blanked.
Live Imaging of SEP-GluA2
Live imaging experiments were performed using primary cultured hippocampal neurons at DIC 17-24, prepared as routinely in the lab (Martin and Henley 2004) , 12-24 h upon infection with Sindbis virus carrying Super Ecliptic Phluorin-GluA2 (SEPGluA2) (Ashby et al. 2004; . Neurons were placed on a heated stage (set at 35°C) of a Nikon TE-2000E inverted microscope (Garden City, NY) and were continually perfused at 3 mL/min with warm Earle's solution containing either TTX (500 nM) alone for the baseline and washout period or TTX (500 nM) and EPO (2.4 IU/mL) during the test period. Low pH external solutions contained equimolar MES instead of HEPES (pH adjusted to 6). NH 4 Cl (50 mM) was used in place of equimolar NaCl to collapse pH gradients. Fluorescence was excited using a 63x water-immersion objective by a 488 nm laser light and emission was detected through a 505 nm long pass filter. Time series were collected as repetitively scanned images. All SEP-GluA2 experiments included a brief (30 s) low pH wash at the end of each experiment, to subtract the remaining signal (internal AMPAR fluorescence) from the total and thus obtain the signal corresponding to surface-expressed AMPARs.
Immunocytochemistry and Confocal Microscopy
DIC 15 and DIC 21 hippocampal neurons were washed with phosphate buffered saline (PBS) (containing in mM: 137 NaCl, 2.1 KCl, 1.8 KH 2 PO 4 , 10 Na 2 HPO 4 .2H 2 O, pH 7.40), containing sucrose whenever needed to correct the solution to the medium osmolarity. Cells were then fixed with 4% phosphate buffered paraformaldehyde (PFA) at RT, for 20 min. Excess of PFA was removed by washing with PBS solution. Cells were permeabilized and blocked for 1 h using PBS containing 1% bovine serum albumin (BSA, Sigma-Aldrich) and 0.1% Tween 20, at RT, and, then, incubated for 1 h, at RT, with a mouse monoclonal primary antibody anti-MAP2 (1:200) and a rabbit polyclonal primary antibody anti-EpoR (1:200; dilution range typically used varies from 1:100 to 1:500, Bernaudin et al. 1999; Sanchez et al. 2009 ), in blocking solution. Washes to remove the excess of primary antibody were then performed in PBS. Hippocampal cultured neurons were subsequently incubated for 2 h, at RT, with a donkey antimouse and donkey antirabbit secondary antibodies, respectively, conjugated to the fluorescent label Alexa Fluor 568 (1:500) and 488 (1:250) in blocking solution. Images of neurons were captured using a confocal point-scanning microscope (Zeiss LSM 710, Germany) with a 63x objective and using the software ZEN 2009 (Carl Zeiss MicroImaging). The pixel size in the object space was 0.13 μm and the captured images were 1024 × 1024 pixels size. Images were stored and analyzed in an uncompressed 16-bit.tiff format.
As a quality control of the anti-EpoR antibody, a blocking peptide competition assay was also performed (Fig. S2 ). In this case, DIC 15 hippocampal neurons were either incubated with the primary antibody or with the primary antibody after being preincubated with the blocking peptide in a proportion of either 1:5 or 1:10 (primary antibody:blocking peptide) (Brownjohn and Ashton 2014) .
EpoR Protein Intensity Quantification
Hippocampal neuronal images with a 16-bit.tiff format were analyzed by using ImageJ (1.46r, NIH) software. EpoR expression in the soma and dendrites was evaluated by quantifying, respectively, the mean gray value of the soma and the mean gray value of the dendrites (by definition, the mean gray value corresponds to the sum of the gray values of all pixels in the selected area divided by the number of pixels). First, the threshold of the whole neuronal area was adjusted on the MAP2 channel, being this region selected as the region of interest (ROI) for the neuron (A). The cell body was selected by drawing a polygon (B) and the whole image was also selected (C). These 3 ROIs were then combined in order to limit the areas to the cell body (A∩B), the dendrites (A/B), and the background (C/A). By measuring, the program gave the mean gray values of the EpoR channel for the 3 combined ROIs plus the background. Then, the background mean gray value was subtracted from the mean gray values of the cell body and dendrites.
Drugs
EPO was purchased from Jena Bioscience (Jena, Germany) and was prepared in distilled water with 0.1% BSA as 100 μg/mL stock solution. TTX (tetrodotoxin citrate), gabazine, DL-APV (DL-2-amino-5-phosphonopentanoic acid), kynurenic acid and CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione) were all purchased from Abcam Biochemicals (Cambridge, MA, USA) and were prepared in distilled water as 1, 10, 50, 100, and 10 mM stock solutions, respectively. Picrotoxin was also purchased from Abcam Biochemicals (Cambridge, MA, USA) and prepared in dimethylsulfoxide (DMSO) as a 50 mM stock solution. K252a was purchased from Tocris Cookson (Ballwin, MO, USA) and made up in a 1 mM stock solution in DMSO. NASPM (1-naphthylacetylspermine) was purchased from Sigma-Aldrich (St. Louis, MO, USA) and prepared as 10 mM stock solution in distilled water. For the live-imaging assays, EPO, TTX, and APV from the same batches as those used for the electrophysiology experiments were used. For the immunocytochemistry procedures, to identify EpoR, a polyclonal rabbit antibody , stock concentration 200 μg/mL) raised against amino acids 488-507, mapping at the C-terminal cytoplasmic domain (amino acids 273-507) of the precursor form of mouse EpoR, was used. As dendritic marker, we used a mouse anti-MAP2 monoclonal antibody (Chemicon, Millipore, No. MAB3418, stock concentration 1 mg/mL). The reagents used for primary hippocampal cultures were purchased from Invitrogen (Carlsbed, CA, USA) and Sigma-Aldrich (St. Louis, MO, USA), unless stated otherwise.
Statistics
All data were tested for normality with Kolmogorov-Smirnov test. Data presented as mean ± standard error of the mean (S.E.M.) have normal distributions and t-test or one-way ANOVA were used to test for significance. Otherwise, data were shown as median and quartiles and Mann-Whitney test was used instead.
Results
EPO Acutely Downregulates Evoked Transmission by Operating Presynaptic Mechanisms
We first re-examined the effect of acute EPO (aEPO) superfusion on afferent-evoked transmission to CA1 neurons, by eliciting orthodromic fEPSPs in hippocampal slices. We found that aEPO significantly inhibited fEPSP slope (Fig. 1B1 ) even when applied at a lower, more physiological concentration (2.4 IU/mL) than previously used (50 IU/mL in Kamal et al. 2011) . EPO signals through EPO receptors (EpoRs), which are frequently found as homodimeric tyrosine kinase receptors (RTKs) in the CNS (Digicaylioglu and Lipton 2011; Ma et al. 2016) . As shown in Figure 1B2 -C, the effect of EPO was prevented by the tyrosine kinase inhibitor, k252a (200 nM), thus suggesting that EPO downregulates afferent-evoked transmission at SC-CA1 synapses through homodimeric EpoRs. Interestingly, we found a consistent time lag of approximately 10 min before aEPO's effect became apparent (Fig. 1B1 ). This lag was described before by Kamal et al. (2011) and may relate to the fact that none of the known signaling molecules downstream to the EpoR are able to directly modulate membrane ionic currents (Ma et al. 2016) , suggesting that involvement of additional steps (e.g., ion channel membrane trafficking or degradation) may be required.
To further dissect the effect of acutely applied EPO on activity-dependent synaptic transmission, namely to determine whether it should be ascribed to presynaptic and/or postsynaptic mechanisms, we performed a PPF protocol, evoked antidromic responses from CA1 neurons and recorded spontaneous changes in membrane potential intracellularly from CA1 pyramidal cells (PCs) soma. We found that (1) the PPF ratio was significantly increased after aEPO (40 min, 2.4 IU/mL) perfusion (n = 5, P = 0.0019, paired t-test; Fig. 1D ), which indicates that EPO reduced the probability of excitatory neurotransmitter release; (2) the popspike amplitude of antidromically evoked responses was unaffected by aEPO (60 min, 2.4 IU/mL; n = 5-6, P = 0.8409, unpaired t-test; Fig. 1E,F) , which suggests that EPO has no effect on nonsynaptically driven excitatory activity of postsynaptic PCs; and (3) the frequency of spontaneous action potentials (AP) recorded from the soma of CA1 PCs, currentclamped to a near-resting membrane potential of −60 mV, was not affected by aEPO (40 min, 2.4 IU/mL) (vehicle: 0.56 [0.26-1.58] Hz; EPO: 0.59 [0.01-1.55] Hz; n = 6-9, P = 0.7756, Mann-Whitney test; data represented as median [interquartile range]; Fig. 1G,H) . Taken together, these data suggest that acute EPO's effect on neuronal transmission is inherently synaptic and that EPO should mainly operate through presynaptic mechanisms to inhibit transmission at SC-CA1 synapses.
Consistent with these results, live-imaging assays of GFPtagged postsynaptic GluA2 AMPA receptor (AMPAR) subunits showed that neither the punctate (synaptic AMPARs) nor the diffuse surface signal (dendritic/perisynaptic AMPARs) were significantly affected by aEPO superfusion (Fig. 2A) . Such lack of effect on postsynaptic AMPAR trafficking could hypothetically be attributed to a lack of expression of EpoR at neuronal dendrites. Immunocytochemistry studies on mature cultured hippocampal neurons showed that the EpoR mainly localized to the cell soma, but was also expressed, at lower levels, in the dendritic compartment (Fig. 2B) . Hence, a lack of expression of the EpoR should not account for the absence of effect on AMPAR trafficking.
Prolonged Exposure to EPO Drives the Homeostatic Upscaling of Excitatory and the Downscaling of Inhibitory Spontaneous Event, Only if Followed by a Recovery Period
The results reported so far suggest that EPO acutely acts to inhibit synaptic transmission, mainly through presynaptic mechanisms. Next, we aimed to test whether a more prolonged exposure to EPO's synaptic manipulation would be able to produce enduring, and perhaps more physiologically relevant, changes in synaptic transmission.
Homeostatic forms of synaptic plasticity ultimately ensure long-term stability of neuronal function, by scaling synapticreceptor currents up or down after prolonged activity decrease or increase, respectively (Turrigiano et al. 1998) . Such synaptic scaling is usually measured as a change in quantal or miniature synaptic transmission ("minis"), which accounts for the APindependent fusion of synaptic vesicles at presynaptic terminals (Sutton et al. 2006 ; reviewed by Pozo and Goda 2010) . Therefore, we next investigated the effects of EPO on spontaneous miniature events.
First, we tested the effect of aEPO (2.4 IU/mL; Fig. 3C ), which significantly decreased the frequency of miniature excitatory postsynaptic currents (mEPSCs) (baseline:0.42 ± 0.10 Hz; after 40 min:0.26 ± 0.08 Hz; n = 7, P = 0.0304, paired t-test; Fig. 3D ) and significantly increased the frequency of miniature inhibitory postsynaptic currents (mIPSC) (baseline:3.55 ± 0.90 Hz; after 40 min:4.10 ± 1.00 Hz; n = 5, P = 0.0088, paired t-test; Fig. 3E ). No significant effects were observed in mEPSC/mIPSC amplitude (Fig. 3D,E) , consistent with our previous thesis that EPO mainly operates through presynaptic mechanisms. Interestingly, these effects endured, even after prolonged (3 h) exposure to EPO (pEPO, 2.4 IU/mL), followed by continuous EPO superfusion throughout the recording period (Fig. 3F) . Indeed, under these conditions, mEPSC frequency was found to be decreased (veh:0.20 ± 0.02 Hz; EPO:0.12 ± 0.02 Hz; n = 5-8 per condition, P = 0.0208, unpaired t-test; Fig. 3G ), and mIPSC frequency was found to be increased (veh:1.67 ± 0.36 Hz; EPO:3.41 ± 0.53 Hz; n = 9 per condition, P = 0.0148, unpaired t-test; Fig. 3H ).
Since changes in the spontaneous-related vesicle pool suffice to elicit homeostatic phenomena (Reese and Kavalali 2015) , we next tested if prolonged (3 h) exposure to EPO (pEPO), followed by a recovery period (1 h) to allow unmasking of the acute effects, could induce lasting homeostatic changes in neuronal transmission. Under these conditions, CA1 pyramidal cells displayed a higher frequency of mEPSCs (veh:0.08 ± 0.01 Hz; EPO:0.29 ± 0.08 Hz; n = 11 per condition, P = 0.0408, unpaired t-test with Welch's correction; Fig. 3J ). Identical effects were observed when recording from hippocampal cultured neurons (Fig. S3A) , suggesting that the homeostatic changes induced by pEPO are inherently synaptic and do not require an intact circuitry. Even though quantal glutamate release at central synapses is assumed to mainly arise from AP-independent vesicle fusion, it can also result from AP-dependent activity (Ye et al. 2010) . For this reason, we addressed the effects of pEPO upon spontaneous EPSCs (sEPSCs), which comprise responses to both types of release. No significant differences in sEPSC amplitude or decay were observed, although there was a trend for increased sEPSC frequency (Fig. S3B,C) . Since EPO does not affect spontaneous AP generation (Fig. 1H) , it is plausible to assume that spontaneous AP-driven events, if unaffected by EPO, might "blur" the scaling of co-recorded AP-independent events.
GABAergic transmission was also affected by pEPO, when followed by a recovery period, through a downscaling in mIPSC frequency (veh:1.72 ± 0.24 Hz; EPO:1.06 ± 0.14 Hz; n = 6-7, P = 0.0312, unpaired t-test; Fig. 3K ), which is reciprocal to the scaling effect of EPO on mEPSCs.
In addition to adjusting synaptic weights, homeostatic plasticity can also promote silent synapse formation (Arendt et al. 2013) or trigger changes in intrinsic membrane properties and neuronal excitability (Desai et al. 1999) , to maintain stability in AP firing rates despite activity manipulation (Hengen et al. 2013; Keck et al. 2013) . In CA1 PCs exposed to pEPO (2.4 IU/mL, 3 h), followed by a recovery period (1 h), whole-cell current-clamp recordings showed no significant differences in instantaneous AP firing frequency in response to soma depolarization (top parameter of fitted curves ± standard error (S.E.): veh:34.89 ± 1.50 Hz, EPO:37.68 ± 2.27 Hz, P > 0.05; slopes of fitted curves ± S.E.: veh:0.0096 ± 0.0018 Hz/pA, EPO:0.0094 ± 0.0024 Hz/pA; n = 15 per condition, P > 0.05, Figure 2 . Acute EPO (aEPO) superfusion does not affect AMPAR trafficking at dendritic spines. (A) The left panels in (A1) and (A2) depict the time courses of normalized changes in SEP-GluA2 fluorescence of punctate and diffuse surface GluA2 signal, respectively (n = 3-4 ROI per neuron; 6 neurons DIC 17-24, from 2 independent cultures). The right panels in (A1) and (A2) depict the averaged fluorescence calculated at baseline and in the last 9 min of aEPO perfusion, with a line connecting averaged values from the same experiment (n = 6). In this set of experiments, EPO was applied for only 12 min to minimize GluA2 fluorescence bleaching. Data represented as mean ± S.E.M. n.s., not significant (paired t-test). The representative dendrite in (A3) illustrates where the punctate (Spine, Sp) and diffuse (Dif) signals were measured. (B,C) Representative images of cultured hippocampal neurons at either DIC 15 (B) or DIC 21 (C) stained for the dendritic marker MAP2 (red) (B1, C1) and the EpoR protein (green) (B2, C2). The panels below (B) and (C) depict virtual images of the neurons in the main panels, generated by the ImageJ software, to exemplify the quantification of the mean gray values. Through the identification of the neuronal area on the MAP2 channel (white painted area on the left virtual image from the MAP2 channel) and cell body region (red polygonal line on the right virtual image from the MAP2 channel), the 2 ROIs (cell body area and processes area) were generated to quantify the EpoR signal intensity in the cell body (white painted area on the left virtual image from the EpoR channel) and in dendrites (white painted area on the right virtual image from the EpoR channel). Scale bar = 30 μm. (D) Histogram depicting the average mean gray values of EpoR protein signal intensity in the cell body (Soma) and in the dendrites (Dend), either at DIC 15 or DIC 21, as indicated below each bar. Data are expressed as mean ± S.E.M. from 60 neurons, taken from 2 independent cultures (30 neurons analyzed per culture) ***P < 0.0001 (paired t-test).
sum-of-squares F-test; Fig. 4A-C) , nor in the maximum AP frequency, RMP, AP firing threshold, or delay to first AP (Table 1) . Hence, prolonged EPO does not seem to affect membrane excitability, nor the ability of the postsynaptic neuron to compute information under conditions of strong depolarization.
Glutamatergic synapses that lack AMPARs and only contain NMDARs are functionally silent despite intact presynaptic (D) and (E) depict the values of frequency (left panels), amplitude (central panels) and decay (right panels) of mEPSC (D) and mIPSC (E) events, which are plotted with a line connecting values at baseline and after 40 min superfusion with aEPO (2.4 IU/mL) (n = 7 for mEPSC recordings; n = 5 for mIPSC recordings). Histograms represent mean ± S.E.M. for each dataset. *P < 0.05, **P < 0.01; n.s., not significant (paired t-test). Top insets: representative mEPSC and mIPSC tracings, at baseline and after aEPO (2.4 IU/mL) superfusion, are shown in panels (D) and (E), respectively. (G,H) Histograms depict the frequency (left panels), amplitude (central panels) and decay (right panels) of mEPSC (G, n = 5-8 per condition) and mIPSC (H, n = 9 per condition) events recorded from CA1 PCs of hippocampal slices incubated for 3 h with either vehicle (black) or pEPO (2.4 IU/mL, gray) and thereafter continuously superfused with EPO (2.4 IU/mL), in order to avoid recovery. Data represented as mean ± S.E.M. *P < 0.05; n.s., not significant (unpaired t-test). Top insets: representative mEPSC (G) and mIPSC (H) tracings, for each condition. (J,K) Histograms depict the frequency (left panels), amplitude (central panels) and decay (right panels) of mEPSC (J, n = 11 per condition) and mIPSC (L, n = 6-7 per condition) events recorded from CA1 PCs of hippocampal slices incubated for 3 h with either vehicle (black) or pEPO (2.4 IU/mL, gray), followed by a 1 h recovery period. Data represented as mean ± S.E.M. *P < 0.05, n.s., not significant (unpaired t-test with Welch's correction for mEPSC data; unpaired t-test for mIPSC data). Top insets:
representative mEPSC (J) and mIPSC (K) tracings, for each condition. Schematic representations of the experimental designs for acute EPO application (C) and prolonged EPO exposure (either with (I) or without (F) a recovery/washout [Wsh] period) are shown. glutamate release, due to the voltage-dependent magnesium blockade of NMDARs (Isaac et al. 1995) . To detect silent synapses, voltage-clamped recordings from CA1 pyramidal cells were performed, and excitatory synaptic transmission was elicited by minimal electrical stimulation, which produced failures in ∼50% of trials (Fig. 4D) . Epochs of 50 trials were recorded at −60 mV and +40 mV for each cell, and the failure rate at these 2 holding potentials was calculated. The failure rate was comparable between the negative and the positive holding potentials both in vehicle-(−60 mV:42.67 ± 3.65%; +40 mV:37.33 ± 7.48%; n = 9, P = 0.4192, paired t-test) and in pEPO-treated slices (−60 mV:43.25 ± 6.58%; +40 mV:46.75 ± 5.10%; n = 8, P = 0.6033, paired t-test; Fig. 4E-G ) for 3 h, followed by a recovery period (1 h). These data suggest that most SC-CA1 synapses are active in our experimental conditions and that the number of silent synapses is not modified by prolonged exposure to EPO.
Prolonged Application of EPO Decreases Basal AfferentEvoked Synaptic Transmission Without Modifying CA1 PC Input-Output Function
Thus far, we have shown that the inhibitory properties of EPO upon synaptic transmission suffice to induce long-lasting changes in synaptic weights, which are homeostatic, since they oppose the effects of aEPO. The increase in mEPSC frequency and the decrease in mIPSC frequency detected when pEPO was followed by a washout period (1 h), are akin to the regulation of the excitatory-inhibitory balance previously described for TTX-based protocols of AD (Echegoyen et al. 2007 ). The use of TTX-based paradigms to induce homeostatic plasticity is well established, as these have been extensively studied in recent years (reviewed, in detail, by Pozo and Goda 2010) . Therefore, they can serve as a good experimental standard, from which comparisons can be drawn, to further our understanding of the newly identified EPO paradigm.
There are at least 2 fundamental differences between these paradigms, since, contrarily to what we have shown for EPO, prolonged exposure to TTX (48-60 h) was able to promote silent synapse formation in cultured hippocampal slices (Arendt et al. 2013) and to increase sensitivity of cultured cortical PCs to injected current by increasing voltage-dependent conductances (Desai et al. 1999) . Notwithstanding, further comparisons are required to attain a fuller picture, particularly on the effects upon evoked transmission and hebbian plasticity phenomena. Our main experimental model (acute hippocampal slices) does not allow for such prolonged incubation periods with TTX. Therefore, we used the model described by Sutton et al. (2006) , who showed that when TTX is combined with blockade of postsynaptic NMDARs, synaptic scaling occurs an order of magnitude faster (3 h). We have previously shown that this combined bath-applied pharmacological AD protocol is able to upscale afferent-evoked excitatory transmission and to lower the threshold for associative, input-specific potentiation of synaptic strength (Félix-Oliveira et al. 2014 ). Thus, we next aimed to evaluate the effect of EPO on evoked synaptic transmission and to contrast it with that elicited by the AD protocol. To this end, we measured extracellularly recorded I/O curves (each variable was calculated as detailed in Fig. S4A ). Consistent with previous results (Félix-Oliveira et al. 2014) , field responses were increased in AD slices (top parameter of fitted curves ± S.E.: veh:3.35 ± 0.20 mV/ms, AD:4.66 ± 0.36 mV/ms; n = 8-9, P = 0.0241, sum-of-square F-test; Fig. 5A ). In stark contrast, pEPO decreased the field responses to afferent stimulation (top parameter of fitted curves ± S.E.: veh:3.35 ± 0.20 mV/ms, EPO:2.68 ± 0.14 mV/ms; n = 9 per condition, P = 0.0161, sum-ofsquare F-test; Fig. 5A ). Simultaneous co-incubation with AD and pEPO (n = 7) did not modify the I/O curve (vs. veh, P = 0.3626), thus suggesting that these modulatory effects are opposite, additive and independent (Fig. 5A) . Importantly, these effects are unrelated to major changes in the recruitment of presynaptic neurons, as the presynaptic fiber volley amplitude (PFVA) was not significantly changed by EPO or AD (Fig. S4B) . When the fEPSP slope is plotted as a function of the PFVA, similar results are rendered, although the inhibitory effect of EPO (top parameter of fitted curves ± S.E.: veh:3.75 ± 0.65 mV/ms, EPO:2.91 ± 0.43 mV/ms; n = 9 per condition, Fig. S4C ) did not reach statistical significance (P = 0.3747, sum-of-square F-test).
We also measured the amplitude of the population spike (popspike) whenever the stimulus intensity was sufficient to elicit it (typically, above 220 μA stimulus intensity), and plotted it against the corresponding fEPSP slope (Fig. 5B) . The popspike amplitude is a measure of CA1 pyramidal cell output, while the fEPSP slope evaluates the response to Schaffer collateral fibers depolarization induced by an electrical stimulus. Therefore, by correlating these 2 variables, we can assess how the hippocampal circuit itself is computing afferent stimulation (Rombo et al. 2015) . Linear fittings of these values show no gross changes induced by either pEPO or AD (Fig. 5B) . More detailed analysis of the results pertaining high stimulus intensities shows a trend for change in popspike amplitude that closely reflects the changes in fEPSP slope (Fig. S4D1) . Therefore, we also calculated the quotient between the popspike amplitude and the fEPSP slope for all stimulus intensities and, accordingly, no significant changes were observed (right inset of Fig. 5B) . Also, subgroup analysis of the results according to stimulus intensity shows no differences between test conditions (Fig. S4D2) . Altogether, these data suggest that the CA1 pyramidal cell output to Schaffer collateral excitation is unaffected by either pEPO or AD.
AD and Prolonged Exposure to EPO Prime Hippocampal Long-Term Potentiation Through Additive Mechanisms
Next, we evaluated how prolonged exposure to EPO affects the capacity of CA1 neurons to undergo hebbian long-term potentiation (LTP). We elicited LTP at SC-CA1 synapses by delivering a weak θ-burst protocol (see Materials and Methods). LTP magnitude following pEPO or AD treatment was significantly higher than in vehicle-treated slices (veh:19.99 ± 2.70%; vs. pEPO:44.44 ± 3.62%, P < 0.01; vs. AD:47.83 ± 3.56%, P < 0.01; n = 9 per condition, one-way ANOVA with Sidak's multiple comparisons test; Fig. 6B,C) . Furthermore, LTP elicited after coincubation with pEPO and the AD protocol was significantly higher than in slices incubated with pEPO or AD alone (AD + pEPO: 69.01 ± 10.36%, P < 0.05 for both comparisons; n = 7-9, one-way ANOVA with Sidak's multiple comparisons test; Fig. 6C ). As previously shown (Kamal et al. 2011) , when EPO was applied only briefly before LTP induction (aEPO) it also significantly increased LTP magnitude (veh:19.99 ± 2.70%, n = 9; vs. aEPO:43.59 ± 4.66%, n = 6, P < 0.05, one-way ANOVA with Sidak's multiple comparisons test; Fig. 6D ,E). However, aEPO did not increase LTP (or PTP) further after AD, yielding a significantly lower LTP magnitude, as compared with the LTP attained after co-incubation with AD and pEPO (AD + aEPO:45.33 ± 4.31%, n = 7; vs. AD+pEPO:69.01 ± 10.36%, n = 7, P < 0.05, one-way ANOVA with Sidak's multiple comparisons test; Fig. 6D,E) . These results indicate that the mechanisms underlying acute EPO-mediated boost of LTP are different from the LTP priming-related changes that take place during the recovery period following prolonged exposure to EPO. Overall, these results also suggest that cumulative synaptic modifications are elicited by prolonged exposure to EPO or AD, rendering them more prone to θ-burst-induced LTP. One plausible explanation is that tuning of glutamatergic transmission by EPO would be different in an activity-deprived network. However, in this regard, we found that the effects of aEPO on mEPSCs and AMPA receptor trafficking were preserved after AD (see Fig. S5A,D) , although the downregulation of fEPSPs was lost (see Fig. S5B ). Another possibility is that the synapses primed for LTP either in activity-deprived conditions or after prolonged exposure to EPO, recruit distinct and independent mechanisms for LTP maintenance. Mature glutamatergic synapses are thought to express only calcium-impermeable (CI), GluA2-containing AMPARs. Contribution of calcium-permeable (CP), GluA2-lacking AMPAR to LTP is more controversial. The current view is that CP-AMPARs are needed for θ-burst LTP induction, but not for tetanus-induced LTP, nor for θ-burst LTP maintenance (Plant et al. 2006 ; see also Adesnik and Nicoll 2007) . To evaluate if CP-AMPAR recruitment could contribute to the higher LTP magnitudes attained after pEPO or after AD, we delivered the same weak θ-burst protocol to 2 independent pathways and added the specific CP-AMPAR extracellular blocker, NASPM (20 μM; Blaschke et al. 1993) , to the superfusion solution, 20 min after LTP induction in the second pathway. NASPM significantly decreased the magnitude of LTP primed by pEPO, but not by AD (pEPO+NASPM:30.90 ± 2.49% vs. AD+NASPM:52.56 ± 4.80%, P < 0.01; pEPO:45.22 ± 4.33% vs. AD:49.71 ± 3.10%, P > 0.05; n = 6-7, one-way ANOVA with Bonferroni's correction; Fig. 7 ). These data suggest that, unlike the mechanisms engaged by AD, LTP primed by prolonged exposure to EPO requires CP-AMPAR for LTP maintenance stage.
Discussion
Research over the last 20 years has highlighted roles for EPO far beyond erythropoiesis (Fond et al. 2012) . Although data from several cohorts uphold the inkling that EPO acts as a cognitive enhancer, its actions on synaptic function and plasticity have remained elusive.
The work herein described is the first to show that EPO is able to elicit homeostatic plasticity phenomena (Supplementary Table 1 ). In this regard, our results revealed that acute EPO acts as an inhibitor of excitatory synaptic transmission, while prolonged exposure to EPO (if followed by a recovery period) produces opposite changes, that is, an upregulation of spontaneous miniature excitatory events. Homeostatic scaling was first described as a slow compensatory upscaling of synaptic strength secondary to loss of AP-driven neurotransmission by long-term (24 h) exposure to TTX (Turrigiano et al. 1998) . Subsequent work showed that when TTX was combined with blockade of NMDAR-mediated responses to stochastic quantal glutamate release, homeostatic adjustment of spontaneous transmission occurred an order of magnitude faster (3 h) (Sutton et al. 2006) . Here, for the first time, we describe a paradigm that induces similar homeostatic changes in spontaneous transmission, while leaving AP-driven events and the number of silent synapses intact. These homeostatic changes require, nonetheless, a recovery period (1 h), in EPO-free aCSF. Such dependence on a reactivation stage has been previously noted for the homeostatic changes in excitatory transmission induced by TTX (Gerkin et al. 2013) . While evaluating spontaneous (AP-dependent and independent) synaptic activity in mice chronically treated with EPO, Adamcio et al. (2008) reported an increase in inhibitory and a decrease in excitatory transmission, which is in apparent conflict with our observations on mEPSC, mIPSC, and sEPSC scaling. This discrepancy may be due to species-and/or age-related differences in EpoR expression, which progressively decreases postnatally (Sanchez et al. 2009 ). Furthermore, chronic EPO administration in vivo (Adamcio et al. 2008 ) may lead to receptor desensitization and/or affect receptor coupling to downstream transduction pathways.
When studying afferent-evoked synaptic transmission, we observed that, unlike AD (Félix-Oliveira et al. 2014), not only does prolonged EPO fail to potentiate, as it decreases the inputoutput relationship. This inhibition could reflect the reduction in the readily releasable pool size shown to occur after prolonged exposure of autaptic neuronal cultures to a low concentration of EPO (Adamcio et al. 2008) . Alternatively, it can be directly linked to the upscaling in spontaneous transmission. Indeed, recent studies challenge the classical association between the fusion rates of spontaneous-and activity-dedicated vesicles, by showing that these 2 forms of release may be independent (Melom et al. 2013) or may even correlate inversely (Peled et al. 2014) .
Intriguingly, EPO attains lasting and opposite modifications of both evoked and spontaneous transmission, with only the latter corresponding to a compensatory homeostatic upscaling. In contrast, AD homeostatically upregulates both spontaneous and electrically evoked transmission (Félix-Oliveira et al. 2014 ). This discrepancy likely relates to a fundamental difference between both paradigms. EPO mainly silences stochastic glutamatergic inputs onto their postsynaptic contacts, while not affecting AP generation. Hence, it affords a more selective modulation of the spontaneous release (not AP-driven) vesicle pool. In contrast, the AD paradigm (Sutton et al. 2006 ) attains a much stronger but less selective inhibition of excitatory transmission. Therefore, while our data support that AP blockade is not an absolute requirement for the rapid scaling of miniature transmission, we also demonstrate that the consequences for synaptic function are not independent of AP blockade. Another advantage in having contrasted EPO with the AD paradigm is that it allowed us to address how EPO affects synaptic (n = 6-7 per condition). Data represented as mean ± S.E.M. **P < 0.01, ***P < 0.001, as compared with vehicle; φφ P < 0.01, φφφ P < 0.001, as compared with AD (one-way ANOVA with Bonferroni's correction).
transmission and plasticity of activity-deprived neurons. Such data is timely, given that EPO is currently considered a potential therapeutic option for patients with ischemic stroke Cramer et al. 2014) . Indeed, the present experimental conditions may resemble those of neurons that remain viable after a stroke event, albeit suffering from activity deprivation due to loss of input from ischemic afferent neurons. Overall, our data also support the emerging view that spontaneous and activity-dependent pools of vesicles are spatially and functionally segregated and may, thus, be independently regulated (Kavalali 2015) . Our results further suggest that EPO acts mainly through presynaptic targets, putatively through one or more of the proteins that comprise the vesicle release machinery preferentially devoted to spontaneous release (Chung et al. 2010) . In this regard, presynaptic-derived forms of homeostatic plasticity have been previously described (Murthy et al. 2001) .
Despite their differences, both prolonged EPO and AD prime plasticity at the hippocampus. LTP has been reported to increase after acute superfusion with EPO (Kamal et al. 2011 ) and following chronic EPO injections (Adamcio et al. 2008) . However, the underlying molecular mechanisms in both time frames seem to be different, as we herein show that, unlike prolonged EPO, acute EPO-driven enhancement of LTP is not cumulative with previous AD. On the one hand, LTP requires intracellular calcium to rise in specific subcellular compartments beyond a critical threshold (Citri and Malenka 2008) and EPO can acutely activate calcium channels, rapidly increasing intracellular Ca 2+ (Koshimura et al. 1999 ). On the other hand, we now show that prolonged EPO causes a homeostatic response in spontaneous transmitter release, which, in and of itself, suffices to elicit postsynaptic plasticity (Nosyreva et al. 2013) and has also been shown to mediate the rapid antidepressant action of ketamine (Autry et al. 2011; Nosyreva et al. 2013 ).
In keeping with the idea that prolonged EPO and AD do not engage the same mechanisms to boost plasticity is the finding that, when co-applied, EPO and AD have an additive influence over LTP. Moreover, pEPO-and AD-primed LTP are maintained through different processes. Vehicle-treated and AD-primed LTPs are not affected by superfusion with a specific CP-AMPAR inhibitor during their consolidation stage, supporting prior evidence that these receptors do not contribute for LTP maintenance (Plant et al. 2006) . In contrast, prior treatment with pEPO leads to an enhanced LTP that is sensitive to CP-AMPAR blockade. Although GluA2-lacking CP-AMPA receptors are virtually excluded from adult synapses (Henley and Wilkinson 2016) , integration of relevant stimuli can recruit them from extrasynaptic pools into the synaptic compartment (Oh et al. 2006) , where a proportionally small increase in CP-AMPARs (~5%) is enough to afford the facilitation of synaptic efficiency that is obtained in θ-burst LTP (Guire et al. 2008) . Our results thus provide the first evidence that mature synapses, under specific circumstances, may recruit CP-AMPARs beyond the induction stage and into LTP maintenance. Future work will elucidate if other paradigms with similar consequences for presynaptic release can engage CP-AMPAR-dependent mechanisms for LTP consolidation or, alternatively, if this is an effect specifically elicited by EPO. However, we cannot exclude that other, concurrent mechanisms also underlie the cumulative effect of prolonged EPO and AD on LTP magnitude. Indeed, long-term (60 h) incubation with TTX was shown to enhance LTP by inducing silent synapse formation (Arendt et al. 2013) , contrarily to what our results suggest for EPO (Fig. 4D-G) .
In conclusion, our data show that EPO acts predominantly as an excitatory transmission inhibitor, acutely downtuning spontaneous and, to a lesser extent, afferent-evoked neurotransmission. Consistently, prolonged exposure to EPO, when followed by a recovery period, selectively elicits homeostatic changes in spontaneous but not in evoked transmission, while leaving neuronal intrinsic properties and the proportion of silent synapses intact. EPO also primes synapses to undergo associative plasticity, recruiting a noncanonical CP-AMPARdependent mechanism for LTP maintenance. Collectively, our results represent a significant advance toward the understanding of the synaptic basis for EPO's procognitive effects and challenge some currently prevailing views on fundamental principles of synaptic transmission and plasticity.
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